Compare ENLV & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENLV | FOA |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | Israel | United States |
| Employees | N/A | 784 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 177.1M |
| IPO Year | 2014 | N/A |
| Metric | ENLV | FOA |
|---|---|---|
| Price | $0.53 | $27.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $20.00 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 343.3K | 56.6K |
| Earning Date | 05-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.58 |
| Revenue Next Year | N/A | $6.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $15.77 |
| 52 Week High | $2.10 | $29.79 |
| Indicator | ENLV | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 26.36 | 81.39 |
| Support Level | N/A | $21.69 |
| Resistance Level | $1.25 | N/A |
| Average True Range (ATR) | 0.05 | 1.65 |
| MACD | -0.01 | 0.87 |
| Stochastic Oscillator | 3.53 | 77.20 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.